155 related articles for article (PubMed ID: 30226086)
1. EBF recommendation on practical management of critical reagents for PK ligand-binding assays.
Pihl S; van der Strate BW; Golob M; Vermet L; Jaitner B; Goodman J; Fjording MS; Timmerman P
Bioanalysis; 2018 Oct; 10(19):1557-1565. PubMed ID: 30226086
[TBL] [Abstract][Full Text] [Related]
2. EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays.
Pihl S; van der Strate BW; Golob M; Ryding J; Vermet L; Jaitner B; Goodman J; Timmerman P
Bioanalysis; 2019 Oct; 11(19):1787-1798. PubMed ID: 31657235
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding assay critical reagents and their stability: recommendations and best practices from the Global Bioanalysis Consortium Harmonization Team.
King LE; Farley E; Imazato M; Keefe J; Khan M; Ma M; Pihl KS; Sriraman P
AAPS J; 2014 May; 16(3):504-15. PubMed ID: 24687208
[TBL] [Abstract][Full Text] [Related]
4. Critical ligand binding reagent preparation/selection: when specificity depends on reagents.
Rup B; O'Hara D
AAPS J; 2007 May; 9(2):E148-55. PubMed ID: 17614357
[TBL] [Abstract][Full Text] [Related]
5. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
Lefor Bradford J
Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
[TBL] [Abstract][Full Text] [Related]
6. European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindset.
Barfield M; Goodman J; Hood J; Timmerman P
Bioanalysis; 2020 Mar; 12(5):273-284. PubMed ID: 31975612
[TBL] [Abstract][Full Text] [Related]
7. Recommendations from the European Bioanalysis Forum on method establishment for tissue homogenates.
Timmerman P; Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lentheric I; McIntosh M; Dzygiel P
Bioanalysis; 2014; 6(12):1647-56. PubMed ID: 25077625
[TBL] [Abstract][Full Text] [Related]
8. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.
Higton D; Young G; Timmerman P; Abbott R; Knutsson M; Svensson LD
Bioanalysis; 2012 Nov; 4(22):2669-79. PubMed ID: 23210650
[TBL] [Abstract][Full Text] [Related]
9. Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents.
Staack RF; Stracke JO; Stubenrauch K; Vogel R; Schleypen J; Papadimitriou A
Bioanalysis; 2011 Mar; 3(5):523-34. PubMed ID: 21388265
[TBL] [Abstract][Full Text] [Related]
10. Japanese bioanalytical method validation guideline: the world's first regulatory guideline dedicated to ligand-binding assays.
Imazato-Hirano M; Taniguchi Y; Kakehi M; Kuze Y; Nakamura T; Minamide Y; Miya K; Hosogi J; Katashima M; Maekawa K; Okuda H; Niimi S; Kawasaki N; Ishii-Watabe A; Katori N
Bioanalysis; 2015; 7(9):1151-6. PubMed ID: 26039811
[No Abstract] [Full Text] [Related]
11. Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.
O'Hara DM; Theobald V; Egan AC; Usansky J; Krishna M; TerWee J; Maia M; Spriggs FP; Kenney J; Safavi A; Keefe J
AAPS J; 2012 Jun; 14(2):316-28. PubMed ID: 22415613
[TBL] [Abstract][Full Text] [Related]
12. Adventures in critical reagent lot changes in ligand-binding assays: redevelopment, bridging and additional processing requirements.
Rauwerdink A; Benson M; Jayne A; Babu S; St Charles J; Smith A
Bioanalysis; 2021 May; 13(10):771-777. PubMed ID: 33884890
[No Abstract] [Full Text] [Related]
13. Implementing a tiered approach to bioanalytical method validation for large-molecule ligand-binding assay methods in pharmacokinetic assessments.
Watson RG; Clements-Egan A; Schantz A; Ware M; Wu B; Yang TY; Shankar G; Marini JC
Bioanalysis; 2017 Sep; 9(18):1407-1422. PubMed ID: 28920457
[TBL] [Abstract][Full Text] [Related]
14. Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissues.
Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lenthéric I; McIntosh M; Dzygiel P; Timmerman P
Bioanalysis; 2014; 6(12):1617-26. PubMed ID: 25077623
[TBL] [Abstract][Full Text] [Related]
15. Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management.
Geist BJ; Egan AC; Yang TY; Dong Y; Shankar G
Bioanalysis; 2013 Jan; 5(2):227-44. PubMed ID: 23330563
[TBL] [Abstract][Full Text] [Related]
16. Life cycle management of critical ligand-binding reagents.
O'Hara DM; Theobald V
Bioanalysis; 2013 Nov; 5(21):2679-96. PubMed ID: 24180507
[TBL] [Abstract][Full Text] [Related]
17. 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).
Gupta S; Richards S; Amaravadi L; Piccoli S; Desilva B; Pillutla R; Stevenson L; Mehta D; Carrasco-Triguero M; Neely R; Partridge M; Staack RF; Zhao X; Gorovits B; Kolaitis G; Sumner G; Stubenrauch KG; Zou L; Amur S; Beaver C; Berger I; Berisha F; Birnboeck H; Bower J; Cho SJ; Cludts I; Cocea L; Donato LD; Fischer S; Fraser S; Garofolo F; Haidar S; Haulenbeek J; Hottenstein C; Hu J; Ishii-Watabe A; Islam R; Jani D; Kadavil J; Kamerud J; Kramer D; Kurki P; MacMannis S; McNally J; Mullan A; Papadimitriou A; Pedras-Vasconcelos J; Ray S; Safavi A; Saito Y; Savoie N; Fjording MS; Scheibner K; Smeraglia J; Song A; Stouffer B; Tampal N; der Strate BV; Verch T; Welink J; Xu Y; Yang TY; Yengi L; Zeng J; Zhang Y; Zhang Y; Zoog S
Bioanalysis; 2017 Dec; 9(24):1967-1996. PubMed ID: 29205064
[TBL] [Abstract][Full Text] [Related]
18. Critical reagents issues & solutions for anti-drug antibody assays.
Vermet L
Bioanalysis; 2021 May; 13(10):779-786. PubMed ID: 33884895
[No Abstract] [Full Text] [Related]
19. 2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (
Hersey S; Keller S; Mathews J; King L; Bandukwala A; Berisha F; Birchler M; Bower J; Clausen V; Duarte J; Garofolo F; Hopper S; Kar S; Mabrouk O; Marshall JC; McGuire K; Naughton M; Saito Y; Schuhmann I; Sperinde G; Teixeira P; Vitaliti A; Wang YM; Wnek R; Zhang Y; Spitz S; Decman V; Eck S; Estevam J; Goihberg P; Alcaide EG; Gonneau C; Hedrick MN; Hopkins G; Junker F; Nuti S; Sommer U; Standifer N; Stevens C; Stevens E; Hendricks C; Wadhwa M; Torri A; Ma M; Harris S; Kumar S; Partridge MA; Caiazzo T; Chilewski S; Cludts I; Coble K; Gorovits B; Grimaldi C; Jordan G; Kamerud J; Leary B; Liang M; Lim H; Mayer A; O'Connor E; Palackal N; Poetzl J; Prior S; Abhari MR; Savoie N; Soo C; Ware M; Wu B; Xu Y; Yang TY; Zoghbi J
Bioanalysis; 2022 May; 14(10):627-692. PubMed ID: 35578974
[TBL] [Abstract][Full Text] [Related]
20. Critical reagent inventory management system and web portal specifically optimized for supporting external clients.
Feauto JA; Davis A; Delhaye RC; Abdeen SJ; Gill HN; Colwell JE; Chiappetta M; Clor EE; Bowsher RR
Bioanalysis; 2022 Jun; 14(12):869-879. PubMed ID: 35904158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
